Champions Oncology, Inc. (CSBR) vs MindWalk Holdings Corp. (HYFT)

A side-by-side comparison of Champions Oncology, Inc. and MindWalk Holdings Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CSBR vs HYFT

growth of $100 · dividends reinvested · last 10y
CSBR +105.4% (+7.5%/yr)HYFT -66.0% (-10.2%/yr)CSBR compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002019202120232025$205$34
CSBR HYFT

CSBR vs HYFT: by the numbers

  • •HYFT is the larger company ($71M vs $68M market cap).
  • •Both run net losses; CSBR's is the smaller (-1.87% vs -105.29% net margin).
  • •CSBR grew revenue faster over the past five years (7.25% vs -4.48% CAGR).

Metrics side by side

Valuation

MetricCSBRHYFT
Forward P/E49.00N/A
P/S ratio1.126.09
P/B ratio17.4914.48
EV / EBITDA256.67N/A

Profitability

MetricCSBRHYFT
Gross margin49.30%60.78%
Operating margin-1.72%-96.01%
Net margin-1.87%-105.29%
ROE-29.15%-250.39%
ROIC-6.75%-153.46%

Growth (annualized)

MetricCSBRHYFT
Revenue CAGR (5Y)7.25%-4.48%
Total return CAGR (5Y)-13.07%-23.93%

Frequently asked

Which has grown faster, CSBR or HYFT?
Over the past five years, CSBR grew revenue faster — CSBR at a 7.25% CAGR versus HYFT at -4.48%.
How have CSBR and HYFT total returns compared?
Over the past 5 years, CSBR delivered -13.07% and HYFT delivered -23.93% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.